Endorsements
The UB Chair recommends requesting its scientific endorsement for any scientific training and/or lecturing event related to the content of the speciality of precision oncology that is in line with the aims of the scientific society. Granting of this endorsement is a way of validating this activity by the UB Chair of Innovation in Precision Oncology.
Endorsement/organisation of Call for 3 Pre-doctoral Fellowships (€90,000): With 5 winning students (3 women and 2 men), these fellowships promote gender equality and provide financial support to young researchers for their doctoral theses.
EPARADELL@clinic.cat
Activities we have already endorsed...
Year | Date | Type | Activity title | |
---|---|---|---|---|
2024 | 04-12-24 | Aval | C17 Update conference on urological tumors | read more |
2024 | C10 y 11/12/2024 | Aval | I Comprehensive training for professional development and well-being in oncology for residents and young adjuncts. Module 1. Time management | read more |
2024 | C10 y 11/12/2024 | Aval |
I Comprehensive training for professional development and well-being in oncology for residents and young adjuncts. Module 1. Time management
I Genetic counseling conference for patients with hereditary cancer prediposition syndromes |
read more |
2024 | Es 08-11-24 | Aval | VIII Conference C17 on lung cancer | read more |
2024 | 12-12-24 | Aval | Challenges and strategies in the management of frail and elderly patients in advanced NSCLC in the first line | read more |
2024 | 09-11-24 | Aval | I Genetic counseling conference for patients with hereditary cancer prediposition syndromes | read more |
2024 | 24, 31/10 y 7/11/24 | Aval | VII Conference C17. Update course in gynaecolgical oncology | read more |
2024 | 18-10-24 | Aval | World Breast Cancer Day 2024 | read more |
2024 | 01-09-24 | Aval | Video capsules for networks: role of oncologist doctor | |
2024 | 07-06-24 | Aval | C17 Multidisciplinary consensus for the best locoregional approach to breast cancer 2024 | |
2024 | 13-05-24 | Aval | Sinergy workshop on translational & clinical oncology applied to environmental & occupational cancer: focus on radon | read more |
2023 | 15/11/23 | Aval | Aseica placement | read more |
2023 | 10/11/23 | Aval | VII Day C17: Lung cancer | read more |
2023 | 8-9/11/23 | Aval | Workshop C17 Refresher in Urological Tumours | read more |
2023 | 19/10/23 | Aval | World Breast Cancer Day | read more |
2023 | 9/06/23 | Aval | VII Day C17: Breast cancer | read more |
2023 | En curso | Aval | EPIMETEO | read more |
2022 | 30/11/22 | Aval | VI Workshop C17: Update on Urological Tumours | read more |
2022 | 19/10/22 | Aval | World Breast Cancer Day - WBCD | read more |
2022 | 17/06/22 | Aval | VI Day C17: Breast cancer | read more |
2022 | 10/05/22 | Aval | 1st Edition Expertalks on Breast Cancer | read more |
2022 | 24/01/22 | Aval | Course "Reimagine your trial" | read more |
2021 | 19/11/21 | Aval | Up-to-date summit Solti | read more |
2021 | 19/10/21 | Aval | World Breast Cancer Day | read more |
2021 | 17/07/21 | Aval | VI Day C17: Breast cancer | read more |
2021 | 20/05/21 | Aval | SOLTI. Up-To-Date Summit 2021 | read more |
2021 | 01/01/21 | Aval | PAIC eHAP Programme | read more |
Knowledge in precision oncology
Expertalks is a series of exclusive events where we talk about new topics in precision oncology from experience and personal opinion.

Previously at EXPERTALKS...
Clinical implications of the intrinsic subtypes of breast cancer: HR+/HER2- disease
Welcome, presentation of the expert and lecture
DRA. MARIA VIDAL Y DR. ALEIX PRAT
Debate
DR. ALEIX PRAT, DRA. MARIA VIDAL, DR. CÉSAR A. RODRÍGUEZ, DR. JOAQUÍN GAVILÁ Y DRA. ELENA GALVE

EXPERT
Dr. Aleix Prat
Hospital Clínic Barcelona-IDIBAPS

COORDINATOR
Dra. Maria Vidal
Hospital Clínic de Barcelona

MODERATOR
Dr. César A. Rodríguez
Hospital Universitario de Salamanca

SPEAKER
Dr. Joaquín Gavilá
Instituto Valenciano de Oncología (IVO)

SPEAKER
Dra. Elena Galve
Hospital Universitario Basurto
Discussions on controversies in the treatment of breast cancer
H2H DEBATES is a meeting space for oncology specialists where the most up-to-date data on breast cancer treatments are presented and discussed.

Previously in H2H DEBATES...
CDK4/6 inhibitors in breast cancer: choosing the best.